MRD analysis and treatment outcome in three children with SET-NUP214-positive hematological malignancies

International Journal of Laboratory Hematology

Volumn 33, Issue 6, 2011, Pages

  Li, W J ^a   Cui, L ^a   Gao, C ^a   Zhao, X X ^a   Liu, S G ^a   Xing, Y P ^a   Zhang, R D ^a   Zhang, D W ^a   Wang, B ^a   Li, Z G ^a   Wu, M Y ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

6 METHYLTHIOINOSINE; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOMONOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW; CANCER CHEMOTHERAPY; CANCER RISK; CASE REPORT; CD34 SELECTION; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; DRUG MEGADOSE; EXON; FOLLOW UP; FUSION GENE; GENETIC TRANSCRIPTION; HUMAN; HYBRID ACUTE LEUKEMIA; IMMUNOPHENOTYPING; KARYOTYPING; LETTER; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LYMPHOBLASTOMA; LYMPHOCYTE STRUCTURE; MINIMAL RESIDUAL DISEASE; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEIC ACID PROBE; OLIGONUCLEOTIDE PROBE; PEDIATRIC HOSPITAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RECOMBINANT PLASMID; REPRODUCIBILITY; SEQUENCE ANALYSIS; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; COMBINED MODALITY THERAPY; FATAL OUTCOME; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTONE CHAPERONES; HUMANS; LEUKEMIA, BIPHENOTYPIC, ACUTE; LYMPHOMA, T-CELL; MALE; NEOPLASM, RESIDUAL; NUCLEAR PORE COMPLEX PROTEINS; ONCOGENE PROTEINS, FUSION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REMISSION INDUCTION; TRANSCRIPTION FACTORS; TREATMENT OUTCOME;

EID: 80054679395     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2011.01343.x     Document Type: Letter

References (9)

1. Beillard E., Pallisgaard N., van der Velden V.H., Bi W., Dee R., van der Schoot E., Delabesse E., Macintyre E., Gottardi E., Saglio G., Watzinger F., Lion T., van Dongen J.J., Hokland P. & Gabert J. (2003) Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program. Leukemia 17, 2474-2486.
2. Cui L., Li Z., Wu M., Li W., Gao C. & Deng G. (2010) Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia. Leukemia Research 34, 1314-1319.
3. van Dongen J.J., Langerak A.W., Bruggemann M., Evans P.A., Hummel M., Lavender F.L., Delabesse E., Davi F., Schuuring E., Garcia-Sanz R., van Krieken J.H., Droese J., Gonzalez D., Bastard C., White H.E., Spaargaren M., Gonzalez M., Parreira A., Smith J.L., Morgan G.J., Kneba M. & Macintyre E.A. (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936 Leukemia 17, 2257-2317.
4. Gorello P., Elia L., La Starza R., Brandimarte L., Varasano E., Vitale A., Pierini V., Longinotti M., Del Poeta G. & Martelli M.F. (2008) TAF1-NUP214 is a new recurrent fusion in a subset (~3%) of acult T-cell acute lymphoblastic leukemia. Haematologica 93s, 198-199.
5. von Lindern M., van Baal S., Wiegant J., Raap A., Hagemeijer A. & Grosveld G. (1992) Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene. Molecular and Cellular Biology 12, 3346-3355.
6. Liu J.Y., Li Z.G., Gao C., Cui L. & Wu M.Y. (2008) [Characteristics of T cell receptor beta gene rearrangements and its role in minimal residual disease detection in childhood T-cell acute lymphoblastic leukemia]. Zhonghua Er Ke Za Zhi 46, 487-492.
7. Pallisgaard N., Hokland P., Riishoj D.C., Pedersen B. & Jorgensen P. (1998) Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 92, 574-588.
8. Van Vlierberghe P., van Grotel M., Tchinda J., Lee C., Beverloo H.B., van der Spek P.J., Stubbs A., Cools J., Nagata K., Fornerod M., Buijs-Gladdines J., Horstmann M., van Wering E.R., Soulier J., Pieters R. & Meijerink J.P. (2008) The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Blood 111, 4668-4680.
9. van der Velden V.H., Cazzaniga G., Schrauder A., Hancock J., Bader P., Panzer-Grumayer E.R., Flohr T., Sutton R., Cave H., Madsen H.O., Cayuela J.M., Trka J., Eckert C., Foroni L., Zur Stadt U., Beldjord K., Raff T., van der Schoot C.E. & van Dongen J.J. (2007) Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia 21, 604-611.